APO RESEARCH · REPORT
Cetirizine Hydrochloride
Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria. It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.
Product & engineering
Understand the product.
Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria. It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.
Selected research
Market Structure
Global Cetirizine Hydrochloride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria. It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.
The major players in the industry are J & J, UCB Pharma, GSK, etc. The proportion of revenue in 2019 is 29.00%, 25.87%, 11.39%. North America has the highest market share by region, accounting for more than 33.8 percent of revenue.
This report provides an overview of the global Cetirizine Hydrochloride market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Cetirizine Hydrochloride and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cetirizine Hydrochloride sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cetirizine Hydrochloride market size, projected growth trends, production technologies, key applications, and end-use industries.
Cetirizine Hydrochloride Segment by Company
J & J
UCB Pharma
GSK
Teva
HUAPONT Pharm
Sun Pharma
Hunan Jiudian Pharm
Lunan Pharma
Mylan
Apotex
Jubilant Life Sciences
HAILISHENG
Cetirizine Hydrochloride Segment by Type
Tablet
Capsule
Solution
Cetirizine Hydrochloride Segment by Application
Hospital
Drug Store
Others
Cetirizine Hydrochloride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cetirizine Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cetirizine Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cetirizine Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Cetirizine Hydrochloride market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cetirizine Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cetirizine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Cetirizine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Capsule
- Solution
Applications
- Hospital
- Drug Store
- Others
Companies covered
- J & J
- UCB Pharma
- GSK
- Teva
- HUAPONT Pharm
- Sun Pharma
- Hunan Jiudian Pharm
- Lunan Pharma
- Mylan
- Apotex
- Jubilant Life Sciences
- HAILISHENG
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cetirizine Hydrochloride Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cetirizine Hydrochloride Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Cetirizine Hydrochloride Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Cetirizine Hydrochloride Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Cetirizine Hydrochloride Market Dynamics
- 2.1 Cetirizine Hydrochloride Industry Trends
- 2.2 Cetirizine Hydrochloride Industry Drivers
- 2.3 Cetirizine Hydrochloride Industry Opportunities and Challenges
- 2.4 Cetirizine Hydrochloride Industry Restraints
3 Cetirizine Hydrochloride Market by Manufacturers
- 3.1 Global Cetirizine Hydrochloride Revenue by Manufacturers (2021-2026)
- 3.2 Global Cetirizine Hydrochloride Sales by Manufacturers (2021-2026)
- 3.3 Global Cetirizine Hydrochloride Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Cetirizine Hydrochloride Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cetirizine Hydrochloride Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Cetirizine Hydrochloride Manufacturers, Product Type & Application
- 3.7 Global Cetirizine Hydrochloride Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cetirizine Hydrochloride Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cetirizine Hydrochloride Players Market Share by Revenue in 2025
- 3.8.3 2025 Cetirizine Hydrochloride Tier 1, Tier 2, and Tier 3
4 Cetirizine Hydrochloride Market by Type
- 4.1 Cetirizine Hydrochloride Type Introduction
- 4.1.1 Tablet
- 4.1.2 Capsule
- 4.1.3 Solution
- 4.2 Global Cetirizine Hydrochloride Sales by Type
- 4.2.1 Global Cetirizine Hydrochloride Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cetirizine Hydrochloride Sales by Type (2021-2032)
- 4.2.3 Global Cetirizine Hydrochloride Sales Market Share by Type (2021-2032)
- 4.3 Global Cetirizine Hydrochloride Revenue by Type
- 4.3.1 Global Cetirizine Hydrochloride Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Cetirizine Hydrochloride Revenue by Type (2021-2032)
- 4.3.3 Global Cetirizine Hydrochloride Revenue Market Share by Type (2021-2032)
5 Cetirizine Hydrochloride Market by Application
- 5.1 Cetirizine Hydrochloride Application Introduction
- 5.1.1 Hospital
- 5.1.2 Drug Store
- 5.1.3 Others
- 5.2 Global Cetirizine Hydrochloride Sales by Application
- 5.2.1 Global Cetirizine Hydrochloride Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cetirizine Hydrochloride Sales by Application (2021-2032)
- 5.2.3 Global Cetirizine Hydrochloride Sales Market Share by Application (2021-2032)
- 5.3 Global Cetirizine Hydrochloride Revenue by Application
- 5.3.1 Global Cetirizine Hydrochloride Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Cetirizine Hydrochloride Revenue by Application (2021-2032)
- 5.3.3 Global Cetirizine Hydrochloride Revenue Market Share by Application (2021-2032)
6 Global Cetirizine Hydrochloride Sales by Region
- 6.1 Global Cetirizine Hydrochloride Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cetirizine Hydrochloride Sales by Region (2021-2032)
- 6.2.1 Global Cetirizine Hydrochloride Sales by Region (2021-2026)
- 6.2.2 Global Cetirizine Hydrochloride Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cetirizine Hydrochloride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Cetirizine Hydrochloride Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Cetirizine Hydrochloride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Cetirizine Hydrochloride Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Cetirizine Hydrochloride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Cetirizine Hydrochloride Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Cetirizine Hydrochloride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Cetirizine Hydrochloride Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Cetirizine Hydrochloride Revenue by Region
- 7.1 Global Cetirizine Hydrochloride Revenue by Region
- 7.1.1 Global Cetirizine Hydrochloride Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Cetirizine Hydrochloride Revenue by Region (2021-2026)
- 7.1.3 Global Cetirizine Hydrochloride Revenue by Region (2027-2032)
- 7.1.4 Global Cetirizine Hydrochloride Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Cetirizine Hydrochloride Revenue (2021-2032)
- 7.2.2 North America Cetirizine Hydrochloride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Cetirizine Hydrochloride Revenue (2021-2032)
- 7.3.2 Europe Cetirizine Hydrochloride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Cetirizine Hydrochloride Revenue (2021-2032)
- 7.4.2 Asia-Pacific Cetirizine Hydrochloride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Cetirizine Hydrochloride Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Cetirizine Hydrochloride Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 J & J
- 8.1.1 J & J Company Information
- 8.1.2 J & J Business Overview
- 8.1.3 J & J Cetirizine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 J & J Cetirizine Hydrochloride Product Portfolio
- 8.1.5 J & J Recent Developments
- 8.2 UCB Pharma
- 8.2.1 UCB Pharma Company Information
- 8.2.2 UCB Pharma Business Overview
- 8.2.3 UCB Pharma Cetirizine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 UCB Pharma Cetirizine Hydrochloride Product Portfolio
- 8.2.5 UCB Pharma Recent Developments
- 8.3 GSK
- 8.3.1 GSK Company Information
- 8.3.2 GSK Business Overview
- 8.3.3 GSK Cetirizine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 GSK Cetirizine Hydrochloride Product Portfolio
- 8.3.5 GSK Recent Developments
- 8.4 Teva
- 8.4.1 Teva Company Information
- 8.4.2 Teva Business Overview
- 8.4.3 Teva Cetirizine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Teva Cetirizine Hydrochloride Product Portfolio
- 8.4.5 Teva Recent Developments
- 8.5 HUAPONT Pharm
- 8.5.1 HUAPONT Pharm Company Information
- 8.5.2 HUAPONT Pharm Business Overview
- 8.5.3 HUAPONT Pharm Cetirizine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 HUAPONT Pharm Cetirizine Hydrochloride Product Portfolio
- 8.5.5 HUAPONT Pharm Recent Developments
- 8.6 Sun Pharma
- 8.6.1 Sun Pharma Company Information
- 8.6.2 Sun Pharma Business Overview
- 8.6.3 Sun Pharma Cetirizine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Sun Pharma Cetirizine Hydrochloride Product Portfolio
- 8.6.5 Sun Pharma Recent Developments
- 8.7 Hunan Jiudian Pharm
- 8.7.1 Hunan Jiudian Pharm Company Information
- 8.7.2 Hunan Jiudian Pharm Business Overview
- 8.7.3 Hunan Jiudian Pharm Cetirizine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Hunan Jiudian Pharm Cetirizine Hydrochloride Product Portfolio
- 8.7.5 Hunan Jiudian Pharm Recent Developments
- 8.8 Lunan Pharma
- 8.8.1 Lunan Pharma Company Information
- 8.8.2 Lunan Pharma Business Overview
- 8.8.3 Lunan Pharma Cetirizine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Lunan Pharma Cetirizine Hydrochloride Product Portfolio
- 8.8.5 Lunan Pharma Recent Developments
- 8.9 Mylan
- 8.9.1 Mylan Company Information
- 8.9.2 Mylan Business Overview
- 8.9.3 Mylan Cetirizine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Mylan Cetirizine Hydrochloride Product Portfolio
- 8.9.5 Mylan Recent Developments
- 8.10 Apotex
- 8.10.1 Apotex Company Information
- 8.10.2 Apotex Business Overview
- 8.10.3 Apotex Cetirizine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Apotex Cetirizine Hydrochloride Product Portfolio
- 8.10.5 Apotex Recent Developments
- 8.11 Jubilant Life Sciences
- 8.11.1 Jubilant Life Sciences Company Information
- 8.11.2 Jubilant Life Sciences Business Overview
- 8.11.3 Jubilant Life Sciences Cetirizine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Jubilant Life Sciences Cetirizine Hydrochloride Product Portfolio
- 8.11.5 Jubilant Life Sciences Recent Developments
- 8.12 HAILISHENG
- 8.12.1 HAILISHENG Company Information
- 8.12.2 HAILISHENG Business Overview
- 8.12.3 HAILISHENG Cetirizine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 HAILISHENG Cetirizine Hydrochloride Product Portfolio
- 8.12.5 HAILISHENG Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Cetirizine Hydrochloride Value Chain Analysis
- 9.1.1 Cetirizine Hydrochloride Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Cetirizine Hydrochloride Production Mode & Process
- 9.2 Cetirizine Hydrochloride Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Cetirizine Hydrochloride Distributors
- 9.2.3 Cetirizine Hydrochloride Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst